Drugs / Allogeneic B7.1/HLA-A1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00534209 | Jan 2009 → Apr 2010 | lung cancer | University of Miami | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic B7.1/HLA-A1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00534209 ↗ |
| Modality | Vaccine | “allogeneic B7.1 and human leukocyte antigen-A1 (HLA-A1) transfected tumor cell vaccine” NCT00534209 ↗ |
| Route | Other | “Given intradermally” NCT00534209 ↗ |